Pharma Reviews
Pages
Home
Pharma News
US FDA News
Pharma Jobs
Tuesday, September 12, 2017
US FDA News: Diabetes Infusion Sets by Medtronic: Recall - Vent Membrane May be Susceptible to Being Blocked by Fluid
May lead to potential over-delivery of insulin shortly after an infusion set change, which may cause hypoglycemia. Posted 09/12/2017
Read more:
Diabetes Infusion Sets by Medtronic: Recall - Vent Membrane May be Susceptible to Being Blocked by Fluid
Newer Post
Older Post
Home